Basit öğe kaydını göster

SERUM TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1) LEVELS IN PANCREATIC ADENOCARCINOMA PATIENTS

dc.contributor.authorKarabulut, Mehmet
dc.contributor.authorAkarsu, Cevher
dc.contributor.authorDagoglu, Nergiz
dc.contributor.authorAlis, Halil
dc.contributor.authorUsul Afsar, Cigdem
dc.contributor.authorKarabulut, Senem
dc.contributor.authorErturk, Kayhan
dc.contributor.authorBilgin, Elif
dc.contributor.authorTas, Faruk
dc.date.accessioned2021-03-05T09:54:47Z
dc.date.available2021-03-05T09:54:47Z
dc.date.issued2016
dc.identifier.citationKarabulut S., Karabulut M., Usul Afsar C., Alis H., Dagoglu N., Akarsu C., Erturk K., Bilgin E., Tas F., "SERUM TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1) LEVELS IN PANCREATIC ADENOCARCINOMA PATIENTS", JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, cilt.79, ss.9-15, 2016
dc.identifier.othervv_1032021
dc.identifier.otherav_a045390c-9913-44a8-a98a-ebc45396585d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/107512
dc.description.abstractObjective: The transforming growth factor beta 1 (TGF-beta 1) is a regulatory cytokine in many tumors. In this study, we aimed to determine the clinical significance of serum TGF-beta 1 levels in patients with pancreatic adenocarcinoma (PA).
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Tıp Bilimleri
dc.titleSERUM TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1) LEVELS IN PANCREATIC ADENOCARCINOMA PATIENTS
dc.typeMakale
dc.relation.journalJOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
dc.contributor.departmentBakirkoy Dr. Sadi Konuk Research & Training Hospital , ,
dc.identifier.volume79
dc.identifier.issue1
dc.identifier.startpage9
dc.identifier.endpage15
dc.contributor.firstauthorID228143


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster